Not logged inTime From Colorectal Cancer Surgery to Adjuvant Chemotherapy Post Hoc Analysis of the SCOT Randomized Clinical Trial
Gogenur, Mikail; Rosen, Andreas Weinberger; Iveson, Timothy; Kerr, Rachel S.; Saunders, Mark P.; Cassidy, Jim; Tabernero, Josep; Haydon, Andrew; Glimelius, Bengt; Harkin, Andrea; Allan, Karen; Pearson, Sarah; Boyd, Kathleen A.; Briggs, Andrew H.; Waterston, Ashita; Medley, Louise; Ellis, Richard; Dhadda, Amandeep S.; Harrison, Mark; Falk, Stephen; Rees, Charlotte; Olesen, Rene K.; Propper, David; Bridgewater, John; Azzabi, Ashraf; Cunningham, David; Hickish, Tamas; Gollins, Simon; Wasan, Harpreet S.; Kelly, Caroline; Goegenur, Ismail; Hollaender, Niels Henrik .png)
Share.png)
SaveShare Save Multiparameter immunoprofiling reveals independent prognostic value of intraepithelial CD8 and intrastromal FoxP3 infiltrate in stage II/III colorectal cancer: Analysis of 3,409 cases from the SCOT and QUASAR2 trialsChurch, D. N.; Frei, A.; McGuigan, A.; Sinha, R.; Harkin, A.; Iveson, T. J.; Saunders, M. P.; Hay, J.; Edwards, J.; Sansom, O. J.; Kelly, C.; Kerr, R.; Kerr, D. J.; Domingo, E.; Koelzer, V. H. Share Save Single cell AI-based detection of DNA mismatch repair deficiency in 1,988 colorectal cancers reveals prognostic and predictive value in the SCOT trialJabbar, F.; Nowak, M.; Rodewald, A-K.; Gneo, L.; Tomasevic, T.; Harkin, A.; Iveson, T. J.; Saunders, M. P.; Kerr, R.; Oien, K. A.; Maka, N.; Hay, J.; Edwards, J.; Tomlinson, I.; Sansom, O. J.; Kelly, C.; Easton, A.; Domingo, E.; Koelzer, V. H.; Church, D. N. Share Save SCOT: Tumor Sidedness and the Influence of Adjuvant Chemotherapy Duration on Disease Free Survival (DFS)Saunders, Mark P.; Iype, Rohan; Kelly, Caroline; Crosby, Jana; Kerr, Rachel; Harkin, Andrea; Allan, Karen; McQueen, John; Pearson, Sarah R.; Cassidy, James; Medley, Louise C.; Raouf, Sherif; Harrison, Mark; Brewster, Alison; Rees, Charlotte; Ellis, Richard; Thomas, Anne L.; Churn, Mark; Iveson, Timothy; Maka, Noori Share Save Codon-specific KRAS mutations predict survival benefit of trifluridine/tipiracil in metastatic colorectal cancervan de Haar, Joris; Ma, Xuhui; Ooft, Salo N.; van der Helm, Pim W.; Hoes, Louisa R.; Mainardi, Sara; Pinato, David J.; Sun, Kristi; Salvatore, Lisa; Tortora, Giampaolo; Zurlo, Ina Valeria; Leo, Silvana; Giampieri, Riccardo; Berardi, Rossana; Gelsomino, Fabio; Merz, Valeria; Mazzuca, Federica; Antonuzzo, Lorenzo; Rosati, Gerardo; Stavraka, Chara; Ross, Paul; Rodriquenz, Maria Grazia; Pavarana, Michele; Messina, Carlo; Iveson, Timothy; Zoratto, Federica; Thomas, Anne; Fenocchio, Elisabetta; Ratti, Margherita; Depetris, Ilaria; Cergnul, Massimiliano; Morelli, Cristina; Libertini, Michela; Parisi, Alessandro; De Tursi, Michele; Zanaletti, Nicoletta; Garrone, Ornella; Graham, Janet; Longarini, Raffaella; Gobba, Stefania Maria; Petrillo, Angelica; Tamburini, Emiliano; La Verde, Nicla; Petrelli, Fausto; Ricci, Vincenzo; Wessels, Lodewyk F. A.; Ghidini, Michele; Cortellini, Alessio; Voest, Emile E.; Valeri, Nicola Share Save Prognostic and predictive value of Immunoscore in stage III colorectal cancer in the combined SCOT and IDEA-HORG studiesChurch, D.; Hay, J.; Sansom, O. J.; Maka, N.; Oien, K. A.; Iveson, T. J.; Saunders, M. P.; Edwards, J.; Harkin, A.; Boukovinas, I.; Moustou, E.; Messaritakis, I.; Chondrozoumaki, M.; Georgoulias, V.; Boquet, I.; Pages, F.; Catteau, A.; Galon, J.; Kelly, C.; Souglakos, I. Share Save Trifluridine/Tipiracil in Metastatic Colorectal Cancer: A UK Multicenter Real-world Analysis on Efficacy, Safety, Predictive and Prognostic FactorsStavraka, Chara; Pouptsis, Athanasios; Synowiec, Alicja; Angelis, Vasileios; Satterthwaite, Liyana; Khan, Sam; Chauhan, Meera; Holden, Chloe; Young, Sally; Karampera, Christina; Martinou, Maria; Mills-Baldock, Tina; Baxter, Mark; Barry, Ainsley; Eccles, Bryony; Iveson, Timothy; Shiu, Kai-Keen; Hill, Mark; Abdel-Raouf, Sherif; Graham, Janet Shirley; Thomas, Anne; Ross, Paul J. Share Save Average cumulative relative dose of adjuvant chemotherapy is more important than average relative dose intensity for colorectal cancer survival, with implications for treating obese patients: The OCTOPUS consortiumSlawinski, C.; Malcomson, L.; Barriuso, J.; Guo, H.; Harkin, A.; Iveson, T.; Glynne-Jones, R.; Van de Velde, C.; Renehan, A. Share Save Share Save Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upArgiles, G.; Tabernero, J.; Labianca, R.; Hochhauser, D.; Salazar, R.; Iveson, T.; Laurent-Puig, P.; Quirke, P.; Yoshino, T.; Taieb, J.; Martinelli, E.; Arnold, D. Share Save A new prognostic and predictive tool for shared decision making in stage III colon cancerSobrero, Alberto F.; Puccini, Alberto; Shi, Qian; Grothey, Axel; Andre, Thierry; Shields, Anthony F.; Souglakos, Ioannis; Yoshino, Takayuki; Iveson, Timothy; Ceppi, Marcello; Bruzzi, Paolo Share Save Guidelines for time-to-event end-point definitions in adjuvant randomised trials for patients with localised colon cancer: Results of the DATECAN initiativeCohen, Romain; Vernerey, Dewi; Bellera, Carine; Meurisse, Aurelia; Henriques, Julie; Paoletti, Xavier; Rousseau, Benoit; Alberts, Steven; Aparicio, Thomas; Boukovinas, Ioannis; Gill, Sharlene; Goldberg, Richard M.; Grothey, Axel; Hamaguchi, Tetsuya; Iveson, Timothy; Kerr, Rachel; Labianca, Roberto; Lonardi, Sara; Meyerhardt, Jeffrey; Paul, James; Punt, Cornelis J. A.; Saltz, Leonard; Saunders, Marck P.; Schmoll, Hans-Joachim; Shah, Manish; Sobrero, Alberto; Souglakos, Ioannis; Taieb, Julien; Takashima, Atsuo; Wagner, Anna Dorothea; Ychou, Marc; Bonnetain, Franck; Gourgou, Sophie; Yoshino, Takayuki; Yothers, Greg; de Gramont, Aimery; Shi, Qian; Andre, Thierry Share Save Share Save 3-month versus 6-month adjuvant chemotherapy for patients with high-risk stage II and III colorectal cancer: 3-year follow-up of the SCOT non-inferiority RCTIvesono, Timothy; Boydo, Kathleen A.; Kerro, Rachel S.; Robles-Zuritao, Jose; Saunders, Mark P.; Briggso, Andrew H.; Cassidyo, Jim; Hollandero, Niels Henrik; Taberneroo, Josep; Haydon, Andrew; Glimeliuso, Bengt; Harkino, Andrea; Allano, Karen; McQueeno, John; Pearsono, Sarah; Waterstono, Ashita; Medleyo, Louise; Wilsono, Charles; Elliso, Richard; Essapen, Sharadah; Dhaddao, Amandeep S.; Harrison, Mark; Falko, Stephen; Raoufo, Sherif; Rees, Charlotte; Oleseno, Rene K.; Proppero, David; Bridgewatero, John; Azzabio, Ashraf; Farrugiao, David; Webbo, Andrew; Cunninghamo, David; Hickish, Tamas; Weavero, Andrew; Gollins, Simon; Wasano, Harpreet; Paulo, James Share Save Aspirin as an adjuvant treatment for cancer: feasibility results from the Add-Aspirin randomised trialJoharatnam-Hogan, Nalinie; Cafferty, Fay; Hubner, Richard; Swinson, Daniel; Sothi, Sharmila; Gupta, Kamalnayan; Falk, Stephen; Patel, Kinnari; Warner, Nicola; Kunene, Victoria; Rowley, Sam; Khabra, Komel; Underwood, Tim; Jankowski, Janusz; Bridgewater, John; Crossley, Anne; Henson, Verity; Berkman, Lindy; Gilbert, Duncan; Kynaston, Howard; Ring, Alistair; Cameron, David; Din, Farhat; Graham, Janet; Iveson, Timothy; Adams, Richard; Thomas, Anne; Wilson, Richard; Pramesh, C. S.; Langley, Ruth Share Save Pattern Recognition Receptor Polymorphisms as Predictors of Oxaliplatin Benefit in Colorectal CancerGray, Victoria; Briggs, Sarah; Palles, Claire; Jaeger, Emma; Iveson, Timothy; Kerr, Rachel; Saunders, Mark P.; Paul, James; Harkin, Andrea; McQueen, John; Summers, Matthew G.; Johnstone, Elaine; Wang, Haitao; Gatcombe, Laura; Maughan, Timothy S.; Kaplan, Richard; Escott-Price, Valentina; Al-Tassan, Nada A.; Meyer, Brian F.; Wakil, Salma M.; Houlston, Richard S.; Cheadle, Jeremy P.; Tomlinson, Ian; Church, David N. Share Save SCOT: a comparison of cost-effectiveness from a large randomised phase III trial of two durations of adjuvant Oxaliplatin combination chemotherapy for colorectal cancerRobles-Zurita, Jose; Boyd, Kathleen A.; Briggs, Andrew H.; Iveson, Timothy; Kerr, Rachel S.; Saunders, Mark P.; Cassidy, Jim; Hollander, Niels Henrik; Tabernero, Josep; Segelov, Eva; Glimelius, Bengt; Harkin, Andrea; Allan, Karen; McQueen, John; Pearson, Sarah; Waterston, Ashita; Medley, Louise; Wilson, Charles; Ellis, Richard; Essapen, Sharadah; Dhadda, Amandeep S.; Hughes, Rob; Falk, Stephen; Raouf, Sherif; Rees, Charlotte; Olesen, Rene K.; Propper, David; Bridgewater, John; Azzabi, Ashraf; Farrugia, David; Webb, Andrew; Cunningham, David; Hickish, Tamas; Weaver, Andrew; Gollins, Simon; Wasan, Harpreet S.; Paul, James Share Save The hard road to data interpretation: 3 or 6 months of adjuvant chemotherapy for patients with stage III colon cancer?Sobrero, A.; Grothey, A.; Iveson, T.; Labianca, R.; Yoshino, T.; Taieb, J.; Maughan, T.; Buyse, M.; Andre, T.; Meyerhardt, J.; Shields, A. F.; Souglakos, I; Douillard, J-Y; Cervantes, A. Share Save Duration of Adjuvant Chemotherapy for Stage III Colon CancerGrothey, A.; Sobrero, A. F.; Shields, A. F.; Yoshino, T.; Paul, J.; Taieb, J.; Souglakos, J.; Shi, Q.; Kerr, R.; Labianca, R.; Meyerhardt, J. A.; Vernerey, D.; Yamanaka, T.; Boukovinas, I.; Meyers, J. P.; Renfro, L. A.; Niedzwiecki, D.; Watanabe, T.; Torri, V.; Saunders, M.; Sargent, D. J.; Andre, T.; Iveson, T. Share Save 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
